Triptorelin extended release injection
What is this medicine?
TRIPTORELIN (TRIP toe rel in) is a man-made hormone. It is used to treat children with early onset of puberty.
How should I use this medicine?
This medicine is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 2 years for selected conditions, precautions do apply.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
suicidal thoughts or other mood changes
Side effects that usually do not require medical attention (report these to your doctor or health care professional if they continue or are bothersome):
pain, redness, or irritation at site where injected
What may interact with this medicine?
medicines for depression, anxiety, or psychotic disturbances
phenothiazines like chlorpromazine, mesoridazine, prochlorperazine, thioridazine
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
suicidal thoughts, plans, or attempt; a previous suicide attempt by you or a family member
an unusual or allergic reaction to triptorelin, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine. You will need important blood work done while you are taking this medicine.
Female patients may experience signs of puberty such as menstrual cycle bleeding during the first 2 months of therapy with this medicine. If this continues, contact your doctor or health care professional.
September 30, 2017